Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending its stock price plummeting by over fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that it coul